Unsatisfactory outcomes in myasthenia gravis: influence by care providers

[1]  J. Ruiz.  Seventy Years On: Historians and Repression During and After the Spanish Civil War , 2009 .

[2]  T. Sharshar,et al.  Immunosuppressive agents for myasthenia gravis. , 2007, The Cochrane database of systematic reviews.

[3]  Y. Ben-Shlomo,et al.  Neurological care and risk of hospital mortality for patients with myasthenia gravis in England , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  W. Köhler.  Psychosocial aspects in patients with myasthenia gravis , 2007, Journal of Neurology.

[5]  M. R. Lee.  The miracle at St Alfege's: seventy years on , 2007, Journal of the Royal Society of Medicine.

[6]  S. Komoly,et al.  Safety of long‐term combined immunosuppressive treatment in myasthenia gravis – analysis of adverse effects of 163 patients , 2006, European journal of neurology.

[7]  N. Gilhus,et al.  Guidelines for treatment of autoimmune neuromuscular transmission disorders , 2006, European journal of neurology.

[8]  N. Gilhus,et al.  Guidelines for the treatment of autoimmune neuromuscular transmission disorders , 2006, European journal of neurology.

[9]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[10]  D. Richman,et al.  Treatment of autoimmune myasthenia gravis , 2003, Neurology.

[11]  P. O'Brien,et al.  Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy , 2001, Neurology.

[12]  S. Chokroverty,et al.  Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert‐Eaton myasthenic syndrome , 2001, Muscle & nerve.

[13]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[14]  W. Nix,et al.  Zur Krankheitsverarbeitung bei Myasthenia gravis im Vergleich mit anderen chronischen neuromuskulärer Erkrankungen , 1998, Der Nervenarzt.

[15]  Harcourt Jk.  Seventy Years , 1998, British medical journal.

[16]  R. Hohlfeld,et al.  Azathioprine toxicity during long‐term immunosuppression of generalized myasthenia gravis , 1988, Neurology.